(Q36071421)

12 August 2017

Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working group (English)

1 reference

metastatic renal cell carcinoma

12 August 2017

1 reference

1 reference

1 reference

13

Robert Motzer

1 reference

12 August 2017

7

Bernard Escudier

1 reference

12 August 2017

2

Patrick Royston

1 reference

12 August 2017

12

Toni K Choueiri

1 reference

12 August 2017

9

Janice Dutcher

1 reference

12 August 2017

Judith Manola

1

1 reference

12 August 2017

Paul Elson

3

1 reference

12 August 2017

Jennifer Bacik McCormack

4

1 reference

12 August 2017

Madhu Mazumdar

5

1 reference

12 August 2017

Sylvie Négrier

6

1 reference

12 August 2017

Tim Eisen

8

1 reference

12 August 2017

Michael Atkins

10

1 reference

12 August 2017

Daniel Y C Heng

11

1 reference

12 August 2017

Ronald Bukowski

14

1 reference

12 August 2017

International Kidney Cancer Working Group

15

1 reference

12 August 2017

language of work or name

English

0 references

publication date

9 August 2011

1 reference

12 August 2017

Clinical Cancer Research

1 reference

12 August 2017

17

1 reference

12 August 2017

16

1 reference

12 August 2017

5443-5450

1 reference

12 August 2017

Cancer statistics, 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387987

Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387987

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387987

A new measure of prognostic separation in survival data

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387987

Metastatic renal carcinoma comprehensive prognostic system

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387987

Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387987

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387987

Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387987

Building multivariable regression models with continuous covariates in clinical epidemiology--with an emphasis on fractional polynomials.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387987

Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3387987

Validation techniques for logistic regression models

23 September 2018

1 reference

12 December 2020

Prognostic factors and survival in patients with metastatic renal cell carcinoma treated with chemotherapy or interferon-alpha

1 reference

12 December 2020

Rising incidence of small renal masses: a need to reassess treatment effect

1 reference

12 December 2020

Interconversion of three measures of performance status: An empirical analysis

1 reference

12 December 2020

Effect of cytokine therapy on survival for patients with advanced renal cell carcinoma

1 reference

12 December 2020

Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d'Immunothérapie

1 reference

12 December 2020

10.1158/1078-0432.CCR-11-0553

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

21828239

1 reference